54646-36-5

Usage

Derived from

1-propanol

Substitution

A methoxy group on the third carbon atom

Substitution

A 4-methylbenzenesulfonate group on the oxygen atom of the methoxy group

Usage

As a reagent in organic synthesis

Hazards

May be harmful if ingested or inhaled, can cause skin and eye irritation

Handling and disposal

Handle with caution and store and dispose of properly to prevent environmental contamination.

Upstream product

• 1589-49-7 methoxypropanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 2387-43-1 2-methyl-2-((tosyloxy)methyl)propane-1,3-diyl bis(4-methylbenzenesulfonate) 

Downstream Products

• 857531-86-3 4-(4-bromo-phenyl)-4-[4-(3-methoxy-propoxy)-phenyl]-piperidine-1-carboxylic acid tert-butyl ester 
• 1399849-95-6 1-[4-(benzyloxy)-3-(3-methoxypropyloxy)phenyl]ethanone 
• 1399849-82-1 1-[3-hydroxy-5-(3-methoxypropoxy)phenyl]ethanone 
• 1399849-83-2 1-[3,5-bis(3-methoxypropoxy)phenyl]ethanone 
• 1227062-66-9 5-[(3-methoxypropyl)thio]-1-phenyl-1H-tetrazole 
• 920296-68-0 4-chloro-N-cyclopropyl-3-(3-methoxy-propoxy)-benzamide 
• 438050-32-9 (R)-2-ethyl-piperazine-1,4-dicarboxylic acid 4-tert-butyl ester 1-[2,6-difluoro-3-(3-methoxy-propoxy)-benzyl]ester 
• 438050-31-8 (R)-2-ethyl-piperazine-1,4-dicarboxylic acid 4-tert-butyl ester 1-[2-fluoro-5-(3-methoxy-propoxy)-benzyl]ester 
• 438050-48-7 2-chloro-6-fluoro-4-(3-methoxy-propoxy)-benzylalcohol 
• 897949-13-2 1-(3-methoxypropyl)-1H-indole-3-carbaldehyde 
• 897948-81-1 3-methoxy-5-(3-methoxy-propoxy)-benzoic acid methyl ester 
• 897949-10-9 C₁₄H₁₈O₆ 
• 853643-67-1 2-(3-methoxy-propoxy)-4-methyl-benzaldehyde 
• 853643-70-6 2-(3-methoxypropoxy)benzaldehyde 

Relevant academic research and scientific papers

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

Disclosed herein are cannabinoid receptor ligands of formula (I) wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS

Disclosed herein are cannabinoid receptor ligands of formula (1) wherein Ring A and R1 are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also described

Semisynthesis and acetylcholinesterase inhibitory activity of stemofoline alkaloids and analogues

Semisynthesis of the known Stemona alkaloids oxystemofoline (7) and methoxystemofoline (8) has been achieved starting from (11Z)-1′,2′- didehydrostemofoline (6), which confirmed their structures and absolute configurations. The synthesis of (1′R)-hydroxys

Compound having polymethine-chain structure, image forming material, planographic printing plate precursor, and image forming method using the same, method of making planographic printing plate, and planographic printing method

A compound having, in its molecule, a polymethine chain structure containing a partial structure represented by the following formula (1-1), and an image forming material containing the same. In the formula (1-1), R1, R2, R3/su

New FBPase inhibitors for diabetes

Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical compositions.

Enantioselective synthesis of cyclic ethers through a vanadium-catalyzed resolution/oxidative cyclization

(Chemical Equation Presented) Two steps, one catalyst: A vanadium(v)-oxo complex with a tridentate Schiff base as an additional ligand catalyzes the title reaction which transforms racemic bishomoallylic α-hydroxyesters into trans-tetrahydropyrans (THPs)

4-PHENYLPIPERIDINE DERIVATIVES AS RENIN INHIBITORS

Compounds of the present invention having the formula (I) exhibit inhibitory activity on the natural enzyme renin. Thus, compounds of formula (I) may be employed for the treatment of hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, unstable coronary syndrome, diastolic dysfunction, chronic kidney disease, hepatic fibrosis, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty, raised intra-ocular pressure, glaucoma, abnormal vascular growth, hyperaldosteronism, cognitive impairment, alzheimers, dementia, anxiety states and cognitive disorders.

Reactivity of Neopentyl-Like Compounds in the Synthesis of Branched Polyethers

Two singly branched symmetrical hexaethers have been synthesized, starting from 2-bromomethyl-2-methyl-1,3-dibromopropane, in a surprisingly efficient one-pot nucleophilic substitution reaction.It is proposed that the expected adverse neopentyl effect is compensated by favourable neighbouring-group participation involving a 'bromonium'-like four-membered-ring transition state.The corresponding trichloride also reacted cleanly, although much more slowly, while the tritosylate gave an oxetane derivative.